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clude, from the least to the most severe, sickness behav-Background
Sepsis is defined as a life‐threatening organ dysfunction
caused by a non‐homeostatic response of the host to an
infection [1]. Sepsis associated encephalopathy (SAE) is
a transient and reversible brain dysfunction, occurring
when the source of sepsis is located outside of the cen-
tral nervous system. SAE affects approximately a third of
septic patients [2] and is a risk factor for long term dis-
ability and mortality [2, 3]. SAE is characterized by an
altered mental status, which may range from delirium to
coma. Electrophysiological and brain imaging anomalies
may be present [4, 5]. The electroencephalogram (EEG)
anomalies of SAE were described and classified by
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© 2017 Heming et al.most severe, excessive theta rhythms, predominant delta
rhythms, triphasic waves and burst suppression [6]. A
recent study reported that seizures were recorded in up
to 15% of patients [4]. However, the exact place of EEG
monitoring in sepsis remains to be defined. Evoked po-
tentials, when investigated in sepsis, show evidence of
increased latencies and decreased amplitudes. Cerebral
imaging shows various patterns of brain injury during
SAE. Brain magnetic resonance imaging (MRI) can be
normal or show focal injuries, such as white matter
hyperintensities or ischemic stroke, in the presence of
disseminated intravascular coagulation (DIC) or of car-
diac arrhythmia [5]. Although there is no hallmark bio-
marker for SAE, elevated plasma levels of S100β or
neuron‐specific enolase (NSE) have been reported. Their
exact significance, however remains unclear [7].Syndromes
ior, delirium and coma (Fig. 1). The most common
physiological and behavioral modifications associated
with any viral or bacterial infection are called “sickness
behavior”. This condition is characterized clinically by
reduced attention and alertness, as well as by eating and
drinking disorders, anxiety and social withdrawal [8].
Biological characteristics include activation of the ad-
renal axis and the adrenergic system. Sickness behavior
relates to the general feeling of being unwell. These
modifications result from the action of proinflammatory
cytokines (interleukin [IL]‐1α and IL‐1β, tumor necrosis
factor (TNF)‐α and IL-6) on centers controlling the
behavioral, neuroendocrine and autonomic responses.
Sickness behavior is considered to be a physiological
reaction to an infectious insult, enabling subjects to
better cope with the disease and to protect them from a
dangerous environment. Sickness behavior can be
maladaptive when its intensity or duration does not
correlate with the intensity of the insult [8].
Fig. 1 Schematic representation of the interaction between sepsis‐
associated neurological syndromes, the affected structures and
clinical outcomes. Modified from [15] with permission
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ring during sepsis is delirium [9]. Delirium is defined by
the DSM‐5 as an acute and fluctuating disturbance in at-
tention and awareness that is not explained by a preex-
isting neurological condition and does not occur in the
context of a severely reduced level of arousal such as
coma [10]. Standardized tools for assessing delirium in
the ICU have been developed, such as the Confusion
Assessment Method for the ICU (CAM‐ICU). Using
such a score, delirium occurs in up to 80% of critically
ill patients [9]. Two major forms of delirium are
described – hypoactive and hyperactive – with a range
of possible forms in between. Delirium is associated with
prolonged mechanical ventilation, increased ICU length
of stay and death [11]. An imbalance between neuro-
transmitters is implicated in the pathophysiology of de-
lirium in the critically ill [12]. However, randomized
trials assessing the neuromodulatory effects of psycho-
tropes in the critically ill failed to show benefit and even
suggested worsened outcomes [3, 13, 14]. Finally, sub-
stance withdrawal, kidney or liver failure, electrolyte
anomalies as well as the toxic effect of drugs may all be
implicated in the genesis of delirium [15].
The most severe form of neurological impairment dur-
ing the course of sepsis is the occurrence of coma. Coma
may in part be linked to the administration of sedative
drugs in a critically ill patient. The depth of coma may
easily be assessed using the Glasgow Coma Scale score or
the FOUR score [16] and is associated with mortality [2].
The FOUR score adds an additional layer of sophistication
to the assessment of coma by scoring brainstem reflexes in
addition to the classical eye, motor and verbal responses
elicited spontaneously or in response to a nociceptivestimuli. For example, an absent cough reflex is associated
with 28‐day mortality in sedated critically ill patients [17].
Long‐term neuropsychological sequelae, including
memory, attention, verbal fluency and executive function
impairment, are frequent in the critically ill [18]. Sepsis
is a major risk factor for long‐term cognitive impairment
[3]. Hospitalization for severe sepsis increases the preva-
lence of moderate to severe cognitive decline by more
than 10% [19]. An episode of acute brain dysfunction
may lead to anxiety, depression, post‐traumatic stress
disorders [20] and self‐harm [21]. Two out of five pa-
tients who have had sepsis are subsequently unable to
return to full‐time employment [22].
Structures
Two distinct pathways transmit inflammatory signals to
the brain in the absence of blood brain barrier disrup-
tion: (1) the vagal nerve senses local inflammation and
transfers the information to the medullary autonomic
nuclei [23, 24]; and (2) circumventricular organs allow
the trafficking of inflammatory mediators into the brain
[25]. The vagal nerve is stimulated shortly after a lipopoly-
saccharide (LPS) challenge [24]. The vagal nerve reaches
the autonomic and neuroendocrine systems [23, 24]. De-
prived of a blood brain barrier, the circumventricular or-
gans are located in the vicinity of the third ventricle and
include the area postrema, which controls nausea and
transmits peripheral vagal nerve information to the rest of
the central nervous system (CNS). Sickness behavior
is induced by the action of pro‐inflammatory cyto-
kines on the brain. In rodents, the systemic or central
administration of IL‐1β induces all the behavioral,
endocrine and autonomic features of sickness behav-
ior [26]. The other proinflammatory cytokines that
affect the brain are IL‐1α, TNF‐α and IL‐6.
Brainstem
A host of arguments point to the existence of brainstem
dysfunction during sepsis, which may be the conse-
quence of neuroinflammation. The area postrema allows
the passage of circulating inflammatory mediators into
the brainstem. Its surgical ablation in rats is equivalent
to a central vagotomy [27]. Therefore, it is conceivable
that excessive inflammatory signaling can be deleterious.
Experimentally, injecting endotoxin in rodents models
the apoptosis of autonomic centers that is induced by
oxidative stress. We have reported multifocal necrotizing
leukoencephalopathy in a septic shock patient, charac-
terized by an intense expression of inflammatory cyto-
kines and neuronal apoptosis within the pons [28].
Neuronal apoptosis within autonomic centers has also
been described [29]. The brainstem is involved in three
general functions: arousal, brainstem reflexes, and con-
trol of vital functions and modulation of the immune
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paired alertness and impaired cardiovascular and immune
controls, thereby leading to increased mortality. We found
that the early abolition of the cough reflex and oculoce-
phalogyric response was independently associated with in-
creased ICU mortality in sedated critically ill patients [17].
Decreased heart rate variability, reflecting an impaired
sympathetic activity originating from the brainstem auto-
nomic centers, is also associated with a worse outcome in
sepsis [30]. Absent EEG reactivity, indicating a dysfunction
of the reticular activating ascending substance, is a pre-
dictor of death in septic patients [4].
Hypothalamus and pituitary axis
Sepsis is associated with multiple neuroendocrine disor-
ders [23, 25, 31–35]. While the initial stage of sepsis is
marked by increased secretion of pituitary hormones not-
ably in response to a decreased sensitivity in peripheral
hormonal receptors, prolonged sepsis is characterized by a
decrease in pituitary hormone release [36]. For example,
septic shock is associated with relative adrenal insuffi-
ciency and increased mortality, responding favorably to
substitutive opotherapy [33, 37]. Septic shock may also be
associated with impaired production of vasopressin [31,
34, 38] due to hyperpolarization of neurons of the or-
ganum vasculosum lamina terminalis (OVLT) region [38].
Amygdala
Psychological consequences of sepsis include anxiety, de-
pression and post‐traumatic stress disorder (PTSD) [39]
all of which involve the amygdala and its network with
the prefrontal cortex, hypothalamus or brainstem. The
amygdala is particularly affected by microglial activation
during sepsis [29, 39]. Studies in military personnel pre-
senting with PTSD showed that the amygdala was desen-
sitized in response to stressful stimuli. The incriminated
mechanism is a dampened response to corticosteroids
which could be overcome by direct corticosterone admin-
istration [40]. A recent study translated these findings in
order to prevent PTSD in sepsis patients [41]. Such a
beneficial effect of corticosteroids may involve non‐genetic
or epigenetic effects of these drugs [42], inducing a major
modulation of aversive memory formation [43].
Hippocampus
Memory impairment can be induced by insults to the
hippocampus or the frontal cortex. Hippocampal atrophy
is associated with loss of memory, such as in Alzheimer’s
disease. In rodents, sepsis is also associated with hippo-
campal dysfunction and subsequent spatial memory alter-
ations evidenced by the Morris Water Maze test [44],
which are correlated with long term potentiation, late
neuronal death, gliosis and increased production of react-
ive oxygen species (ROS). TNF‐α, caspase 1 and hypoxiaseem to be implicated in the pathogenesis of this hippo-
campal dysfunction [45].
Frontal cortex
The prefrontal cortex and other sensorimotor areas con-
stitute the frontal cortex. Cognitive defects occurring
after frontal cortex injuries include mainly impaired
memorization, attention and executive functions. Ultra-
structural neuronal anomalies were shown within the
sensorimotor cortex in a dog model of endotoxic shock.
Pre‐frontal cortex‐related cognitive functions including
memorization and verbal fluency are frequently affected
after sepsis [19]. Neuroinflammation within the frontal
cortex results in cognitive impairment [46].
White matter
As shown by MRI studies, sepsis can induce axonal dam-
age; which may contribute to the cognitive decline [46].
Processes
Three major processes are involved in the pathophysi-
ology of SAE including diffuse neuroinflammation, is-
chemic processes and excitotoxicity.
Neuroinflammation
Microglial cells are the mononuclear phagocytes of the
brain, implicated in immune defense and synaptic plasti-
city. Microglia express membrane‐bound receptors that are
able to detect endogenous or exogenous danger signals.
Microglial activation implies a level of blood brain barrier
disruption or the local release of proinflammatory media-
tors. Microglial activity ranges from proinflammatory to
anti‐inflammatory. Microglial activation is a frequent
neuropathological feature of SAE [29, 47]. The modulation
of microglial activity, although still in the pre‐clinical phase,
may be an interesting option for treating SAE [48].
Astrocytes are supportive glial cell components. Astro-
cytes are involved in neuroinflammation as they are re-
active and able to secrete various mediators [49].
Astrocytes are thus involved in cerebral blood flow con-
trol through the release of mediators, such as nitric
oxide (NO), prostaglandins and arachidonic acid [50].
Astrocytes regulate the concentration of neurotransmit-
ters, such as glutamate, GABA, and glycine, in the syn-
aptic space by taking up any excess neurotransmitter,
preventing their potential for accumulation [51]. Animal
studies consistently report the presence of astrogliosis
during SAE. By contrast, no such finding has been re-
ported in man, possibly due to technical issues.
Neuroinflammation affects cellular metabolism, poten-
tially leading to oxidative stress and mitochondrial dys-
function [52]. Mitochondrial dysfunction has been found
in the brain of septic animals, associated with the pro-
duction of oxygen/nitrogen reactive species [53].
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The gliovascular unit associates endothelial cells, astro-
cytes and pericytes [54]. Exchanges between the brain and
components of the blood occur through endothelial cells.
Astrocytes regulate water and ionic homeostasis through
the transmembrane channel aquaporin 4 (AQP4). Gliovas-
cular units are implicated in adjusting blood flow at the
arteriolar and capillary levels in order to provide the ener-
getic requirement of a given cerebral area [54].
Ischemia can result from macrocirculatory dysfunc-
tion, including hypotension, decreased cerebral flow and
impaired autoregulation. Sepsis induces activation of
cerebral endothelial cells which, by impairing micro-
vascular tone and activating coagulation, promotes is-
chemic and/or hemorrhagic lesions of the brain [55].
Some experimental data indicate that during the early
stages of sepsis, there is an increased expression of
endothelial NO synthase (eNOS), which causes add-
itional NO release and enhances the activation of cere-
bral endothelial cells [56]. This endothelial activation,
coupled with the neuroinflammation process, can result
in impaired blood brain barrier permeability, upregu-
lated AQP4, parenchymal infiltration by neutrophils, and
the activation of astrocytes [57]. MRI studies have shown
blood brain barrier breakdown in patients with septic
shock [58], possibly originating from the perivascular
spaces of Wirchow‐Robin, which may go on to involve
the whole white matter. It has to be noted that posterior
reversible encephalopathy syndromes have been reported
in septic patients [59]. Experimental studies confirm that
blood brain barrier impairment relates to a dysfunction
of tight junction proteins, such as occludin, ZO‐1, ZO‐2,
claudin‐3 and claudin‐5 [60].
Neurovascular coupling is a specific brain mechanism of
vasoregulation that adapts local cerebral blood flow to the
neural metabolic needs. SAE is associated with neurovas-
cular uncoupling due to microcirculatory dysfunction and
low blood flow. In septic patients, a discrepancy between
neuronal activation, increased metabolic needs and vascu-
lar reactivity is observed [61].
The combination of macro‐ and micro‐circulatory de-
fects, endothelial dysfunction and neurovascular un-
coupling contribute to ischemic lesions, which were
constantly observed in a post‐mortem study of patients
who died of septic shock. These ischemic lesions were
found in brain areas sensitive to ischemia (i. e., the
hippocampus, the basal ganglia, frontal cortex, dentate
gyrus and the bulbar olive) but also, and specifically to
sepsis, in the nuclei of the autonomic nervous system
(i. e., amygdala, anterior and posterior hypothalamus,
locus coeruleus). Similarly, pronounced neuronal apop-
tosis was observed in these areas. Furthermore, brain
hemorrhages were found in 17–26% of these neuropatho-
logical cases [47].Neurotransmitter dysfunction
A small number of brain structures, namely the amyg-
dala, nucleus tractus solitarii and locus coeruleus, are
particularly vulnerable to sepsis and liable to neuronal
apoptosis [29]. Glutamate plays a role in neuronal apop-
tosis during sepsis, through excitoxicity [62]. For ex-
ample, the recycling and glutamate‐stimulated export of
ascorbate by astrocytes are inhibited during sepsis [63].
Interestingly, analysis of the cerebrospinal fluid of pa-
tients with SAE showed a decrease in the levels of ascor-
bate, an anti‐oxidant produced by astrocytes that plays a
role in neuroprotection [64]. When activated, microglia
cells also release large amounts of glutamate [65].
The dopaminergic, β‐adrenergic [66], the GABA recep-
tor [67], and the cholinergic [52] systems are all impaired
during sepsis. An imbalance between dopaminergic and
cholinergic neurotransmission might be particularly in-
volved in delirium [12]. However, cholinergic drugs, such
as rivastigmine [13] as well as anti‐dopaminergic drugs,
such as haloperidol [14], do not reduce the incidence or
duration of delirium. The use of GABA‐agonists, such as
benzodiazepines, actually increases the risk of delirium
[3], which is reduced by noradrenergic drugs, such as dex-
medetomidine [68]. Impaired neurotransmission might re-
sult from the production of NO [69], but also from
circulating neurotoxic amino‐acids (ammonium, tyrosine,
tryptophan and phenylalanine) that are released in excess
by the liver and muscles during sepsis [70]. Metabolic dis-
orders and drug toxicity (e. g., sedatives, analgesics, antibi-
otics …) contribute to neurotransmitter dysfunction.
Conclusion
The clinical spectrum of SAE includes sickness behavior,
delirium, focal deficits and coma associated or not with
brainstem reflex loss. It is associated with increased
mortality and long‐term psychocognitive impairment.
SAE results from inflammatory, ischemic and neurotoxic
processes that affect, in particular, the frontal cortex, the
hippocampus, the amygdala and the brainstem. Its diag-
nosis essentially relies on neurological examination and
EEG findings, which may indicate the need for brain im-
aging. In daily clinical practice, brain infection has to be
ruled out whenever suspected, as well as drug toxicity or
metabolic disturbances. There is no specific treatment
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